Meloxicam
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis, with certain IV formulations approved for moderate-to-severe pain management in adults.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 131 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾
Meloxicam carries a serious FDA boxed warning about two major risks: heart events and stomach/intestinal bleeding.
Like all NSAIDs, meloxicam raises the risk of heart attack and stroke, which can be fatal. This risk can appear early in treatment and may increase the longer you take it. Meloxicam must not be used right before or after coronary artery bypass graft (CABG) heart surgery.
Meloxicam also raises the risk of serious bleeding, ulcers, and holes (perforation) in the stomach or intestines — any of which can be life-threatening. These problems can happen at any time and may occur without warning signs. Older adults and people who have had stomach ulcers or GI bleeding before are at the greatest risk.
📖 Meloxicam: Patient Information Guide
A plain-language walkthrough of Meloxicam — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Meloxicam is an NSAID approved for several inflammatory and pain conditions depending on the product and formulation.
- Osteoarthritis — treated by meloxicam tablets, oral suspension, Zybic oral suspension, and meloxicam capsules
- Rheumatoid arthritis — treated by meloxicam tablets and oral suspension (including Zybic)
- Juvenile rheumatoid arthritis (JRA) in patients 2 years of age and older — treated by meloxicam oral suspension and Zybic oral suspension
- Juvenile rheumatoid arthritis in patients weighing at least 60 kg — treated by meloxicam tablets
- Moderate-to-severe pain in adults — managed by Qamzova (IV injection), Xifyrm (IV injection); these are not recommended when rapid pain relief is needed
⚙️How it works▾
Meloxicam blocks two enzymes called COX-1 and COX-2 (cyclooxygenase-1 and -2). These enzymes produce prostaglandins — chemical messengers that make nerves more sensitive to pain, cause inflammation, and contribute to fever. By reducing prostaglandin production in body tissues, meloxicam eases pain, swelling, and stiffness. The full mechanism is not completely understood, but inhibiting prostaglandin synthesis is considered the primary way it works.
💊How it's taken▾
Oral forms — tablets, capsules, and suspension — are taken by mouth once daily and can generally be taken with or without food. Always shake the oral suspension gently before use. IV formulations (Qamzova, Xifyrm) are given once daily as an intravenous injection in a healthcare setting only. Always use the lowest effective dose for the shortest time your condition requires, and follow your prescriber's specific instructions — do not switch between meloxicam formulations without guidance, as they are not interchangeable.
🤒Side effects — in detail▾
The most common side effects reported in clinical trials include:
- Diarrhea
- Indigestion or upset stomach (dyspepsia)
- Nausea
- Upper respiratory tract infection
- Flu-like symptoms
- Headache
- Swelling (edema)
- Abdominal pain
Serious reactions — including GI bleeding, heart attack, stroke, liver damage, severe allergic reactions, and dangerous skin reactions — can also occur and require immediate medical attention.
⚠️Warnings & precautions▾
- Heart attack and stroke: Meloxicam raises the risk of serious cardiovascular events including heart attack and stroke, which can be fatal. This risk can begin early in treatment and may increase with longer use or higher doses. People with existing heart disease or risk factors face the highest absolute risk.
- GI bleeding, ulcers, and perforation: Meloxicam can cause life-threatening stomach or intestinal bleeding, ulcers, or perforation — sometimes without any warning symptoms. Older adults and those with a history of ulcers or GI bleeding are at greatest risk.
- Kidney and liver toxicity: Long-term use can harm the kidneys, and rare but serious liver injury has been reported. Monitor kidney and liver function, especially in at-risk patients.
- Heart failure and high blood pressure: Meloxicam can worsen both conditions and may blunt the effectiveness of blood pressure medications and diuretics.
- Serious skin reactions: Rare but life-threatening skin conditions such as Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported. Stop the medication at the first sign of a rash.
- Pregnancy risks: Meloxicam can harm an unborn baby, particularly after 20 weeks of pregnancy, and should be avoided from about 30 weeks onward.
🔀What it interacts with▾
Meloxicam interacts with several common medications — tell your prescriber and pharmacist everything you take:
- Warfarin and other anticoagulants — combined use significantly raises the risk of serious bleeding
- Aspirin — even low-dose aspirin combined with meloxicam increases GI bleeding risk; meloxicam is not a substitute for aspirin for heart protection
- SSRIs and SNRIs (certain antidepressants) — may increase bleeding risk further when combined with meloxicam
- ACE inhibitors, ARBs, and beta-blockers (blood pressure drugs) — meloxicam can reduce their effectiveness and, in vulnerable patients, worsen kidney function
- Diuretics (water pills) — meloxicam may reduce their fluid-removing and blood pressure-lowering effects
- Lithium — meloxicam can raise lithium blood levels, increasing the risk of lithium toxicity
- Methotrexate — combination raises risk of serious toxicity including low blood counts and kidney problems
- Cyclosporine — combination may increase kidney toxicity
- Other NSAIDs or salicylates — do not take meloxicam with another NSAID; risk of GI toxicity increases with little added benefit
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not take meloxicam if you have ever had an allergic reaction — including hives, asthma attacks, or anaphylaxis — to aspirin or any other NSAID
- Do not take meloxicam right before or after coronary artery bypass graft (CABG) surgery
- Tell your doctor if you have a history of stomach ulcers, GI bleeding, heart disease, high blood pressure, heart failure, or kidney or liver problems
- Pregnant women should avoid meloxicam from about 30 weeks of pregnancy onward; use between about 20 and 30 weeks should be limited to the lowest dose for the shortest time
- Women who are having difficulty getting pregnant should tell their doctor — NSAIDs may reversibly delay ovulation
- There are no human data on meloxicam in breast milk; discuss risks and benefits with your doctor if you are breastfeeding
- Older adults are at higher risk for serious heart, GI, and kidney problems; start at the lowest possible dose and be monitored regularly
- Patients with mild to moderate kidney impairment generally do not need a dose adjustment, but those on hemodialysis have a lower maximum daily dose limit; meloxicam is not recommended in severe renal impairment
- Patients with mild to moderate liver impairment generally do not need a dose adjustment, but meloxicam should be used cautiously; it has not been well studied in severe liver impairment
🚑If you take too much▾
Taking too much meloxicam can cause drowsiness, nausea, vomiting, and stomach pain — these usually improve with supportive care. More serious but rare effects include GI bleeding, high blood pressure, acute kidney failure, and in severe cases, breathing problems or coma. There is no specific antidote; if you think someone has taken too much, call Poison Control at 1-800-222-1222 right away.
📡Pharmacodynamics — effects in the body▾
Meloxicam has pain-relieving (analgesic), anti-inflammatory, and fever-reducing (antipyretic) effects. It works by lowering prostaglandin levels in peripheral tissues — prostaglandins are chemical signals that make nerve endings more sensitive to pain and drive inflammation. By reducing these signals, meloxicam decreases pain sensitivity and swelling in affected joints and tissues.
🔬Pharmacokinetics — how your body processes it▾
When taken orally, meloxicam is well absorbed — peak blood levels are typically reached within about 4 to 6 hours, and the drug reaches steady-state levels in the body by around day 5 of regular use. It is heavily bound to plasma proteins (about 99%) and is broken down mainly in the liver, primarily through the CYP2C9 enzyme. The body clears meloxicam roughly equally through urine and stool (mostly as metabolites), with an elimination half-life of approximately 15 to 20 hours — meaning it stays in the body long enough to support once-daily dosing.
📦How to store it▾
Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) .
📄 Written from Meloxicam’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Meloxicam
113 supplements and herbal products have documented interactions with Meloxicam in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 5
- Moderate · 81
- Minor · 27
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Meloxicam has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Meloxicam — the kind of thing our pharmacy team would talk through with you at the counter.
What conditions is meloxicam actually used to treat? ▾
Can I take meloxicam with food, and does it matter what time of day I take it? ▾
What side effects should I expect, and which ones mean I should call someone? ▾
I take a blood thinner. Is it safe to use meloxicam too? ▾
Is meloxicam safe to take during pregnancy? ▾
Does it matter which meloxicam product I use — can I just switch to whatever's cheapest? ▾
Is Meloxicam available over the counter? ▾
When was Meloxicam first available? ▾
Who makes Meloxicam? ▾
💬 Answers drafted from Meloxicam’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Meloxicam comes
Meloxicam is available in 4 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Meloxicam tablets treat osteoarthritis
- Meloxicam tablets treat rheumatoid arthritis
- Meloxicam tablets treat juvenile rheumatoid arthritis in patients weighing at least 60 kg
- Meloxicam tablets are taken by mouth once daily
- Meloxicam tablets may be taken with or without food
- Meloxicam tablets are not interchangeable with other meloxicam formulations even at the same milligram strength
- Use the lowest effective dose for the shortest duration needed
Capsule
How this form is used
- Meloxicam capsules are indicated for management of osteoarthritis pain
- Meloxicam capsules are taken by mouth once daily
- Meloxicam capsules are not interchangeable with other oral meloxicam formulations even at the same milligram strength
- Use the lowest effective dose for the shortest duration needed
Oral suspension
How this form is used
- Meloxicam oral suspension treats osteoarthritis
- Meloxicam oral suspension treats rheumatoid arthritis
- Meloxicam oral suspension and Zybic treat juvenile rheumatoid arthritis in patients 2 years of age and older
- Zybic treats juvenile rheumatoid arthritis with dosing individualized by the child's weight
- Shake the oral suspension gently before each use
- Meloxicam oral suspension and Zybic may be taken without regard to timing of meals
- Meloxicam oral suspension is not interchangeable with other meloxicam formulations even at the same milligram strength
- Zybic is not interchangeable with other approved oral meloxicam formulations even at the same milligram strength
Injection
How this form is used
- Qamzova is indicated for management of moderate-to-severe pain in adults, alone or combined with non-NSAID pain relievers
- Xifyrm is indicated for management of moderate-to-severe pain in adults, alone or combined with non-NSAID pain relievers
- Qamzova and Xifyrm are not recommended alone when rapid pain relief is required due to delayed onset of action
- Qamzova and Xifyrm are given by intravenous injection in a healthcare setting — not for home use
- Patients must be well hydrated before receiving Qamzova or Xifyrm to reduce the risk of kidney toxicity
- Use for the shortest duration consistent with individual treatment goals
- A short-acting non-NSAID pain reliever may be needed if Qamzova or Xifyrm does not provide adequate relief for the full dosing interval
📊 Meloxicam across the U.S. market
How Meloxicam appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (21) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Meloxicam is used
A general measure of how commonly Meloxicam is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Meloxicam is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Meloxicam prescribed? Of the 1,597 medications we measure, Meloxicam ranks #64 by Medicaid prescriptions — more than 96% of them.
Utilization by Meloxicam product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
meloxicam 15 MG Oral Tablet Most dispensed
Summed across the 11 of 409 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 152695
meloxicam 7.5 MG Oral Tablet
Summed across the 12 of 354 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311486
meloxicam 10 MG Oral Capsule
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1722357
meloxicam 5 MG Oral Capsule
Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1722349
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Meloxicam, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 27 of 773 listed Meloxicam NDCs with Medicaid activity.
🔍 Compare Meloxicam products
A representative set of FDA-listed product records for Meloxicam — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 5 mg | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 10 mg | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 5 mg | Oral | Egalet US Inc. | NDA | Find on DailyMed ↗ |
| 10 mg | Oral | Egalet US Inc. | NDA | Find on DailyMed ↗ |
| 5 mg | Oral | Lupin Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 10 mg | Oral | Lupin Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 5 mg | Oral | Novitium Pharma LLC | ANDA | View NDC → |
| 10 mg | Oral | Novitium Pharma LLC | ANDA | View NDC → |
| 💊Injection | ||||
| 30 mg/mL | Intravenous | Azurity Pharmaceuticals, Inc. | NDA | View NDC → |
| 30 mg/mL | Intravenous | Baudax Bio, Inc. | NDA | View NDC → |
| 30 mg/mL | Intravenous | Nanjing Delova Biotech Co., Ltd. × 2 listings | NDA | View NDC → |
| 💊Oral suspension | ||||
| 7.5 mg/5 mL | Oral | Avondale Pharmaceuticals, LLC × 2 listings | NDA | View NDC → |
| 7.5 mg/5 mL | Oral | Emerald Therapeutics, LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 7.5 mg/5 mL | Oral | Redmont Pharmaceuticals, LLC | NDA | View NDC → |
| 💊Tablet | ||||
| 7.5 mg | Oral | A-S Medication Solutions × 9 listings | ANDA | View NDC → |
| 15 mg | Oral | A-S Medication Solutions × 13 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Advanced Rx of Tennessee, LLC × 6 listings | ANDA | View NDC → |
| 15 mg | Oral | Advanced Rx of Tennessee, LLC × 9 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 3 listings | ANDA | View NDC → |
| 15 mg | Oral | Advanced Rx Pharmacy of Tennessee, LLC × 3 listings | ANDA | View NDC → |
| 7.5 mg | Oral | AiPing Pharmaceutical, Inc × 3 listings | ANDA | View NDC → |
| 15 mg | Oral | AiPing Pharmaceutical, Inc × 3 listings | ANDA | View NDC → |
| 15 mg | Oral | American Health Packaging × 2 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 5 listings | ANDA | View NDC → |
| 15 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 7 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Ascent Pharmaceuticals, Inc | ANDA | View NDC → |
| 15 mg | Oral | Ascent Pharmaceuticals, Inc | ANDA | View NDC → |
| 7.5 mg | Oral | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Asclemed USA, Inc. × 4 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 7.5 mg | — | Aurobindo Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 15 mg | — | Aurobindo Pharma Limited | DRUG FOR FURTHER PROCESSING | View NDC → |
| 15 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 7.5 mg | Oral | AvPAK × 3 listings | ANDA | View NDC → |
| 15 mg | Oral | AvPAK × 3 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Bryant Ranch Prepack × 11 listings | ANDA | View NDC → |
| 15 mg | Oral | Bryant Ranch Prepack × 17 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Camber Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Carlsbad Technology, Inc. × 3 listings | ANDA | View NDC → |
| 15 mg | Oral | Carlsbad Technology, Inc. × 3 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Chartwell RX, LLC × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Chartwell RX, LLC × 2 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Cipla USA Inc. × 3 listings | ANDA | View NDC → |
| 15 mg | Oral | Cipla USA Inc. × 3 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Clinical Solutions Wholesale, LLC | ANDA | View NDC → |
| 7.5 mg | Oral | Coupler LLC × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Coupler LLC | ANDA | View NDC → |
| 7.5 mg | Oral | Denton Pharma, Inc. DBA Northwind Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Denton Pharma, Inc. DBA Northwind Pharmaceuticals × 2 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Direct Rx × 3 listings | ANDA | View NDC → |
| 15 mg | Oral | Direct Rx × 3 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Direct_Rx × 5 listings | ANDA | View NDC → |
| 15 mg | Oral | Direct_Rx | ANDA | View NDC → |
| 7.5 mg | Oral | Exelan Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Exelan Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 7.5 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 💊Bulk drug substance | ||||
| 1 kg/kg | — | Anonima Materie Sintetiche and Affini (AMSA) Spa × 2 listings | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 25 kg/25 kg | — | Apex Healthcare Limited | BULK INGREDIENT | View NDC → |
| 50 kg/50 kg | — | Arch Pharmalabs Limited | BULK INGREDIENT | View NDC → |
| 50 kg/50 kg | — | Aurobindo Pharma Limited | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | Bidachem S.p.a. × 2 listings | BULK INGREDIENT | View NDC → |
| 25 kg/25 kg | — | Cipla Ltd. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Derivados Quimicos SAU | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Ipca Laboratories Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Kalchem International inc | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Letco Medical, Llc | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 g/g | — | Medisca Inc. | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Professional Compounding Centers of America dba PCCA | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | View NDC → |
| 1 kg/kg | — | Quimica Sintetica S.A. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Shandong Xinhua Pharmaceutical Company Limited | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Spectrum Laboratory Products, Inc. | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Swati Spentose Private Limited | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Unichem Laboratories Limited, India | BULK INGREDIENT | View NDC → |
| 1 g/g | — | Xenex Laboratories Inc | BULK INGREDIENT | View NDC → |
| 1 kg/kg | — | Zydus Lifesciences Limited | BULK INGREDIENT | View NDC → |
Showing 200 of 385 products — FDA National Drug Code Directory. See every product, package size and price: browse all 385 Meloxicam NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Meloxicam — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Meloxicam in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Meloxicam went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 41493 7 dose forms · 12 strengths
-
Dose form (SCDF) Disintegrating Oral Tablet RxCUI 2118580In current FDA listingsClinical drug / strength (SCD) 7.5 MGRxCUI 211858915 MGRxCUI 2118581 -
Dose form (SCDF) Injectable Solution RxCUI 372752In current FDA listingsClinical drug / strength (SCD) 5 MG/MLRxCUI 1086707 -
Dose form (SCDF) Injection RxCUI 2281105In current FDA listingsClinical drug / strength (SCD) 1 ML meloxicam 30 MG/MLRxCUI 2281106 -
Dose form (SCDF) Oral Capsule RxCUI 446251In current FDA listings -
Dose form (SCDF) Oral Suspension RxCUI 597405In current FDA listings -
Dose form (SCDF) Oral Tablet RxCUI 372754In current FDA listings -
Dose form (SCDF) Rectal Suppository RxCUI 372753No current FDA listingClinical drug / strength (SCD) 7.5 MGRxCUI 22692315 MGRxCUI 152694
Look up RxCUI 41493 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Meloxicam is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Meloxicam belongs to the Nonsteroidal Anti-inflammatory Drug class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 131 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Avondale Pharmaceuticals, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.